pI: 6.6919 |
Length (AA): 178 |
MW (Da): 21010 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128999)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G20550 | FHA domain-containing protein DDL |
Babesia bovis | BBOV_III011470 | FHA domain containing protein |
Brugia malayi | Bm1_47765 | FHA domain containing protein |
Caenorhabditis elegans | CELE_C32E8.5 | Protein C32E8.5 |
Cryptosporidium parvum | cgd1_3470 | fork head domain protein, putative |
Drosophila melanogaster | Dmel_CG17168 | CG17168 gene product from transcript CG17168-RA |
Echinococcus granulosus | EgrG_000218600 | Smad nuclear interacting protein 1 |
Entamoeba histolytica | EHI_029080 | FHA domain protein, putative |
Echinococcus multilocularis | EmuJ_000218600 | Smad nuclear interacting protein 1 |
Homo sapiens | ENSG00000163877 | Smad nuclear interacting protein 1 |
Loa Loa (eye worm) | LOAG_03856 | FHA domain-containing protein |
Mus musculus | ENSMUSG00000050213 | Smad nuclear interacting protein 1 |
Neospora caninum | NCLIV_022960 | GM13279, related |
Oryza sativa | 4339498 | Os05g0545500 |
Oryza sativa | 4339499 | Os05g0545600 |
Oryza sativa | 4339504 | Os05g0546600 |
Plasmodium berghei | PBANKA_1406300 | fork head domain protein, putative |
Plasmodium falciparum | PF3D7_1307800 | fork head domain protein, putative |
Plasmodium knowlesi | PKNH_1408200 | conserved Plasmodium protein, unknown function |
Plasmodium knowlesi | PKNH_1408100 | fork head domain protein, putative |
Plasmodium vivax | PVX_122222 | hypothetical protein, conserved |
Plasmodium vivax | PVX_122218 | fork head domain protein, putative |
Plasmodium yoelii | PY00031 | Drosophila melanogaster RE68879p, putative |
Saccharomyces cerevisiae | YLR016C | Pml1p |
Schistosoma japonicum | Sjp_0205210 | Smad nuclear-interacting protein 1, putative |
Schistosoma mansoni | Smp_137380 | smad nuclear interacting protein |
Schmidtea mediterranea | mk4.005770.02 | Smad nuclear-interacting protein 1 |
Toxoplasma gondii | TGME49_201790 | FHA domain-containing protein |
Theileria parva | TP02_0790 | hypothetical protein |
Trichomonas vaginalis | TVAG_426690 | smad nuclear interacting protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C32E8.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C32E8.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C32E8.5 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_201790 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.